Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the best low priced biotech stocks to invest in. On April 13, Vir Biotechnology, Inc. (NASDAQ:VIR) announced that the first patient had been dosed in one ...

Virtual event highlights cutting‑edge innovations driving advances in healthcare, sustainability, and emerging ...

Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the must-buy small cap stocks to buy. On April 13, Vir Biotechnology, Inc.

Food technology and ingredients company Kerry Group has opened its expanded biotechnology manufacturing facility in Carrigaline in Co Cork, significantly increasing its capacity to produce lactase ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that CEO Kabir Nath will ...

Moderna is expected to announce its fiscal first-quarter earnings next month, and analysts project a high single-digit ...

Eli Lilly has agreed to acquire Kelonia Therapeutics for up to $7 billion, in a deal that would bolster the buyer’s oncology pipeline with KLN-1010, a lentiviral in vivo CAR T therapy under study in ...

Vir Biotechnology has dosed the first patient in one of three expansion cohorts in its ongoing Phase I clinical trial of ...

COMPASS Pathways (CMPS) stock jumped 25% after Trump's executive order on psychedelic research. Positive Phase 3 data boosts ...

Scientists are uncovering a hidden layer of coral reef ecosystems, one dominated not by visible marine life, but by vast and largely unexplored microbial communities.

Enveric Biosciences (ENVB) stock exploded 160%+ after Trump's executive order to accelerate psychedelic drug reviews and $50M ...

Worth up to $7 billion, Lilly’s second recent acquisition of a company in the space is centered around a cell therapy that’s ...